Sugi Predict

Sugi Predict / Compounds / SCHEMBL306823

SCHEMBL306823

SCHEMBL306823

FC(F)(F)Oc1ccc(-c2ccccc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIF11 P52732 3/20 0.50
▸ AURKA O14965 1/20 0.50
▸ TPX2 Q9ULW0 1/20 0.50
▸ SERPINE1 P05121 1/20 0.50
▸ SCN5A Q14524 5/20 0.49
▸ IGF2BP2 Q9Y6M1 1/20 0.48
▸ ACP1 P24666 1/20 0.46
▸ AKR1C2 P52895 1/20 0.46
▸ AKR1C1 Q04828 1/20 0.46
▸ NISCH Q9Y2I1 1/20 0.46
▸ CHRM5 P08912 2/20 0.46
▸ HDAC3 O15379 2/20 0.45
▸ HDAC4 P56524 2/20 0.45
▸ HDAC1 Q13547 2/20 0.45
▸ HDAC7 Q8WUI4 2/20 0.45
▸ HDAC2 Q92769 2/20 0.45
▸ HDAC10 Q969S8 2/20 0.45
▸ HDAC11 Q96DB2 2/20 0.45
▸ HDAC8 Q9BY41 2/20 0.45
▸ HDAC6 Q9UBN7 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18293362 1.00 KIF11 (0.50) KIF11AURKATPX2SERPINE1SCN5A
SCHEMBL28910204 0.98 SERPINE1 (0.49) KIF11AURKATPX2SERPINE1SCN5A
SCHEMBL9602945 0.93 SERPINE1 (0.47) KIF11AURKATPX2SERPINE1SCN5A
SCHEMBL28334199 0.88 SERPINE1 (0.47) KIF11AURKATPX2SERPINE1SCN5A
SCHEMBL29628993 0.86 SCN5A (0.54) KIF11AURKATPX2SCN5AIGF2BP2
SCHEMBL26803468 0.86 ACP1 (0.48) KIF11AURKATPX2SERPINE1SCN5A
SCHEMBL27862141 0.85 KIF11 (0.47) KIF11GRIN2B
SCHEMBL168125 0.85 KIF11 (0.47) KIF11GRIN2B
SCHEMBL29699519 0.85 SCN5A (0.46) KIF11AURKATPX2SERPINE1SCN5A
SCHEMBL15807435 0.84 SERPINE1 (0.54) KIF11AURKATPX2SERPINE1SCN5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012054782-A2 FLUOROALKOXYLATION OF ORGANIC COMPOUNDS PRESIDENTS AND FELLOWS OF HARVARD COLLEGE (US) 2012-04-26 — — WO claimed
EP-1660439-A2 ARYL AND HETEROARYL COMPOUNDS, COMPOSITIONS, AND METHODS OF USE Transtech Pharma, Inc. (US) 2006-05-31 — — EP claimed
US-20050059705-A1 Aryl and heteroaryl compounds, compositions, and methods of use VTVX HOLDINGS I LLC 2005-03-17 — — US claimed
WO-2005014533-A2 ARYL AND HETEROARYL COMPOUNDS, COMPOSITIONS, AND METHODS OF USE TRANSTECH PHARMA, INC. (US) 2005-02-17 — — WO claimed
US-20040034028-A1 4-(biphenylcarbonylamino)piperidine derivatives as mtp inhibitors MERCK PATENT GMBH (DE) 2004-02-19 — — US claimed
EP-1335912-A1 4-(BIPHENYLCARBONYLAMINO)PIPERIDINE DERIVATIVES AS MTP INHIBITORS MERCK PATENT GmbH (DE) 2003-08-20 — — EP claimed
WO-2002042291-A1 4-(BIPHENYLCARBONYLAMINO)PIPERIDINE DERIVATIVES AS MTP INHIBITORS MERCK PATENT GMBH (DE) 2002-05-30 — — WO claimed
EP-0334911-B1 SUBSTITUTED PHENYLTRIFLUORMETHYLETHERS MERCK PATENT GmbH (DE) 1993-02-10 — — EP claimed
US-20260109693-A1 BUTENOLIDE COMPOUNDS CONTAINING THIAZOLIDINONE STRUCTURE AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF UNIV CHINA AGRICULTURAL (CN) 2026-04-23 — — US disclosed
EP-4568963-A1 TERTIARY AMINE SUBSTITUTED BICYCLIC COMPOUNDS USEFUL AS T CELL ACTIVATORS Bristol-Myers Squibb Company (US) 2025-06-18 — — EP disclosed
EP-4514133-A1 FUNGICIDAL COMPOSITIONS Syngenta Crop Protection AG (CH) 2025-03-05 — — EP disclosed
CN-116507695-B Aromatic isothiocyanates 默克专利股份有限公司 2025-02-25 — — CN disclosed
WO-2024198335-A1 BUTENOLIDE COMPOUNDS CONTAINING THIAZOLIDINONE STRUCTURE AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF 中国农业大学 2024-10-03 — — WO disclosed
CN-118434716-A Isothiocyanoethynyl benzene derivatives 默克专利股份有限公司 2024-08-02 — — CN disclosed
US-6022995-A PESTICIDES BAYER AKTIENGESELLSCHAFT (DE) 2000-02-08 — — US disclosed
US-5602282-A CATALYTIC HYDROGENATION OF ALPHA-HYDROXYKETOXIMES BAYER AKTIENGESELLSCHAFT (DE) 1997-02-11 — — US disclosed
CN-1122797-A Process for the preparation of 2-amino-2-arylethanols and novel intermediates BAYER AG (DE) 1996-05-22 — — CN disclosed
EP-0696576-A2 Process for the preparation of 2-amino-2-arylethanols and intermediates BAYER AG (DE) 1996-02-14 — — EP disclosed
EP-0334911-B1 SUBSTITUTED PHENYLTRIFLUORMETHYLETHERS MERCK PATENT GmbH (DE) 1993-02-10 — — EP disclosed
US-4157344-A REACTING PHENOLS WITH A PERHALOMETHANE AND HYDROGEN FLUORIDE E. I. DU PONT DE NEMOURS AND COMPANY (US) 1979-06-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050059705-A1 Aryl and heteroaryl compounds, compositions, and methods of use TFPI, F3, F2 KIF11 4478/4885AURKA 2404/4885TPX2 321/4885
US-20040034028-A1 4-(biphenylcarbonylamino)piperidine derivatives as mtp inhibitors LIPC, CETP, MTTP KIF11 4245/4885AURKA 4266/4885TPX2 2313/4885
US-20260109693-A1 BUTENOLIDE COMPOUNDS CONTAINING THIAZOLIDINONE STRUCTURE AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF CYP51A1, CYP4F12, CYP4F11 KIF11 3892/4885AURKA 4840/4885TPX2 3985/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.